Activation of the fibrinolytic cascade early in pregnancy among women with spontaneous preterm birth

Obstetrics and Gynecology

Volumn 112, Issue 5, 2008, Pages 1116-1122

  Catov, J M ^a   Bodnar, L M ^b   Hackney, D ^b   Roberts, J M ^b   Simhan, H N ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; THROMBIN ANTITHROMBIN COMPLEX; ANTITHROMBIN III; ANTITHROMBIN III PROTEASE COMPLEX; ANTITHROMBIN III-PROTEASE COMPLEX; PEPTIDE HYDROLASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CHRONIC DISEASE; CONTROLLED STUDY; DOSE RESPONSE; DYSLIPIDEMIA; FEMALE; FIBRINOLYSIS; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; INFLAMMATION; INTRAUTERINE GROWTH RETARDATION; LOGISTIC REGRESSION ANALYSIS; PREECLAMPSIA; PREMATURE LABOR; PRIORITY JOURNAL; RACE; SAMPLING; TERM BIRTH; ADOLESCENT; BLOOD; PREGNANCY; PREMATURITY; RISK; SECOND TRIMESTER PREGNANCY;

ADOLESCENT; ADULT; ANTITHROMBIN III; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; FIBRINOLYSIS; HUMANS; ODDS RATIO; PEPTIDE HYDROLASES; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREMATURE BIRTH; YOUNG ADULT;

EID: 58149308812     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31818aa5b5     Document Type: Article

References (31)

1. Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Kirmeyer S, et al. Births: final data for 2004. Natl Vital Stat Rep 2006;55:1-101.
2. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 2001;323:1213-17.
3. Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 2001;357:2002-6.
4. Smith GD, Sterne J, Tynelius P, Lawlor DA, Rasmussen F. Birth weight of offspring and subsequent cardiovascular mortality of the parents. Epidemiology 2005;16:563-9.
5. Arias F, Rodriquez L, Rayne SC, Kraus FT. Maternal placental vasculopathy and infection: two distinct subgroups among patients with preterm labor and preterm ruptured membranes. Am J Obstet Gynecol 1993;168:585-91.
6. Germain AM, Carvajal J, Sanchez M, Valenzuela GJ, Tsunekawa H, Chuaqui B. Preterm labor: placental pathology and clinical correlation. Obstet Gynecol 1999;94:284-9.
7. Fareed J, Hoppensteadt DA, Leya F, Iqbal O, Wolf H, Bick R. Useful laboratory tests for studying thrombogenesis in acute cardiac syndromes. 1998;44:1845-53.
8. Elovitz MA, Baron J, Phillippe M. The role of thrombin in preterm parturition. Am J Obstet Gynecol 2001;185:1059-63.
9. Rosen T, Kuczynski E, O'Neill LM, Funai EF, Lockwood CJ. Plasma levels of thrombin-antithrombin complexes predict preterm premature rupture of the fetal membranes. J Matern Fetal Med 2001;10:297-300.
10. Romero R, Espinoza J, Gonçalves LF, Kusanovic JP, Friel L, Hassan S. The role of inflammation and infection in preterm birth. Semin Reprod Med 2007;25:21-39.
11. Institute of Medicine. Preterm birth: causes, consequences, and prevention. Washington (DC): National Academies Press; 2006.
12. Catov JM, Bodnar LM, Ness RB, Barron SJ, Roberts JM. Inflammation and dyslipidemia related to risk of spontaneous preterm birth. Am J Epidemiol 2007;166:1312-9.
13. Edison RJ, Berg K, Remaley A, Kelley R, Rotimi C, Stevenson RE, et al. Adverse birth outcome among mothers with low serum cholesterol. 2007;120:723-33.
14. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342: 836-43.
15. Bek KM, Nielsen FR, Qvist I, Rasmussen PE, Tobiassen M, C-reactive protein (CRP) and pregnancy. An early indicator of chorioamnionitis. A review. Eur J Obstet Gynecol Reprod Biol 1990;35:29-33.
16. Pitiphat W, Gillman MW, Joshipura KJ, Williams PL, Douglass CW, Rich-Edwards JW. Plasma C-reactive protein in early pregnancy and preterm delivery. Am J Epidemiol 2005;162: 1108-13.
17. National Cholesterol Education Program. Third report of the National Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Bethesda (MD): National Institutes of Health; 2002.
18. Catov JM, Bodnar LM, Kip KE, Hubel C, Ness RB, Harger G, et al. Early pregnancy lipid concentrations and spontaneous preterm birth. Am J Obstet Gynecol 2007;107:610e1-7.
19. Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med 2000;342:1500-7.
20. Shapiro S, Wilk M. An analysis of variance test for normality (complete samples). Biometrika 1965;52:591-611.
21. Hosmer D, Lemeshow S. Applied logistic regression. 2nd ed. New York (NY): John Wiley & Sons, Inc; 2000.
22. Eichinger S, Weltermann A, Philipp K, Hafner E, Kaider A, Kittl EM, et al. Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden. Thromb Haemost 1999;82: 1232-6.
23. Kleinbaum D, Kupper L, Muller K, Nizam A. Applied regression analysis and other multivariable methods. 3rd ed. Pacific Grove (CA): Duxbury Press; 1998.
24. Bellart J, Gilabert R, Fontcuberta J, Carreras E, Miralles RM, Cabero L. Coagulation and fibrinolysis parameters in normal pregnancy and in pregnancy complicated by intrauterine growth retardation. Am J Perinatol 1998;15:81-5.
25. Cadroy Y, Grandjean H, Pichon J, Desprats R, Berrebi A, Fournie A, et al. Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia. Br J Obstet Gynaecol 1993; 100:416-20.
26. Chaiworapongsa T, Espinoza J, Yoshimatsu J, Kim Y, Bujold E, Edwin S, et al. Activation of the coagulation system in preterm labor and preterm premature rupture of membranes. J Matern Fetal Neonatal Med 2002;11:368-73.
27. Mutoh S, Kobayashi M, Hirata J, Itoh N, Maki M, Komatsu Y, et al. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium. Agents Actions Suppl 1992;38:320-9.
28. Even-Ram SC, Grisaru-Granovsky S, Pruss D, Maoz M, Salah Z, Yong-Jun Y, et al. The pattern of expression of protease-activated receptors (PARs) during early trophoblast development. J Pathol 2003;200:47-52.
29. Pedersen B, Holscher T, Sato Y, Pawlinski R, Mackman N. A balance between tissue factor and tissue factor pathway inhibitor is required for embryonic development and hemostasis in adult mice. Blood 2005;105:2777-82.
30. Sagastagoitia JD, Saez Y, Vacas M, Narvaez I, Saez de Lafuente JP, Molinero E, et al. Association between inflammation, lipid and hemostatic factors in patients with stable angina. Thromb Res 2007;120:53-9.
31. Strong JP, Malcom GT, McMahan CA, Tracy RE, Newman WP 3rd, Herderick EE, et al. Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA 1999;281:727-35.